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Summary 
Type 1 and type 2 cloned T helper (Th) cells are believed to require different antigen-presenting 
cell (APC)-derived costimuli for proliferation. In the case of Thl-cloned T cells, CD28 signaling 
costimulates production of autocrine interleukin 2 (IL-2). Th2 cells produce their autocrine growth 
factor, IL-4,  without costimulation, but require APC-derived costimuli,  or IL-1, to respond 
to IL-4. Here we demonstrate that engagement of CD28 on Th2 ceils with anti-CD28 antibody 
or with APC-associated B7 costimulates Th2 responsiveness to IL-4 but does not affect IL-4 
or IL-2 production by Th2 cells. Costimulation of Th2 cells via CD28 appears  to involve the 
induction of IL-1 production by Th2 cells, which acts in an autocrine fashion to induce IL-4 
responsiveness.  These results suggest that CD28-induced costimulation plays an important role 
in responses mediated by both types of Th cells. 
T 
wo major groups of cloned Th cells can be distinguished 
on the basis of the cytokines they produce. Most cloned 
Thl  cells  secrete IL-2  and  IFN-7  as  signature cytokines, 
whereas cloned Th2 cells secrete IL-4, IL-5, IL-6, and IL-10 
(1-5). The proliferative response to antigen of Thl and Th2 
cells requires the action of the autocrine growth factors IL-2 
and IL-4, respectively. Activation of the growth pathway of 
both types of clones requires not only the engagement of 
the TCR, but additional costimulatory signals provided by 
APC. However, costimulatory signaling of the proliferation 
of Thl and Th2 cells occurs at different steps of T cell activa- 
tion.  Costimulation of Thl cells is mediated in large part 
by increasing the production of IL-2 and other cytokines by 
the cells (5, 6).  In contrast, evidence suggests that engage- 
ment of the TCR of Th2 ceils is a sufficient signal to activate 
production of the autocrine growth factor IL-4, but costimu- 
lation is necessary to render the cells responsive to IL-4 (7-9). 
The costimulation of Thl and Th2 cells has been thought 
to be mediated by distinct APC-derived signals.  In the case 
of Thl  cells  and  freshly isolated  murine  CD4 +  T  cells, 
costimulation can be mediated by engagement of cell surface 
CD28, by anti-CD28 mAb, or by its natural ligand B7, which 
is expressed by most APC. CD28 is a member of the Ig su- 
perfamily expressed on most T ceils (10, 11). CD28 costimu- 
lation of Thl ceils results in a dramatic increase in the levels 
of IL-2 and other lymphokine transcripts,  as a result of  elevated 
transcript stabilization as well as increased cytokine gene tran- 
scription (12-15).  Engagement of the TCR of cloned Thl 
cells in the absence of costimulatory signals is not a neutral 
event, but  induces long-term T  cell unresponsiveness,  or 
anergy, and may represent a mechanism of nondeletional toler- 
ance in vivo (5, 6). Costimulation of cloned Thl cells with 
anti-CD28  mAb prevents the induction of anergy (16). 
In contrast, previous studies suggest that APC-derived IL-1 
plays an important role as a costimulatory signal for Th2 cells. 
Exogenously supplied IL-1 costimulates responses of Th2 cells 
stimulated with  mitogens,  anti-TCR  antibodies,  or fixed 
antigen-pulsed APC (2, 7, 8). Furthermore, exogenously sup- 
plied IL-1 renders resting Th2 cells sensitive to proliferation 
induced by IL-4. Some APCs, such as macrophages, produce 
high levels of IL-1 (17). However, some potent APCs, such 
as dendritic cells, reportedly do not produce IL-1 (18). Hence, 
APC-derived IL-1 may not be the sole costimulatory signal 
for Th2 cells. 
In this report, we show that cloned Th2 cells express CD28 
on their surface and that engagement of CD28 costimulates 
Th2 cell proliferation. CD28 engagement induced increased 
Th2 IL-4 responsiveness through an IL-l-dependent mecha- 
nism and was required for the stimulation of Th2 cell prolifer- 
ation by splenic APC and antigen. The results suggest that 
the CD28 costimulation pathway is common to both major 
classes of Th cell clones, although the stage of action of CD28 
costimulation differs. 
Materials and Methods 
Cell Lines and Reagents.  The AKR-derived D10.G4 (19) and 
BALB/c-derived CDC-35 (20) cloned Th2 cell lines have been de- 
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T. Briner and M. Gefter (Massachusetts  Institute of Technology, 
Cambridge, MA), and has been described previously (16). The HT-2 
indicator cell line has also been previously described (21). RPMI 
media was obtained from Bin Whittaker, Inc. (Walkersville, MD) 
and  fetal bovine serum  (FBS)'  from Sigma Chemical  Co.  (St. 
Louis, MO). The anti-CD28 mAb (37.51) was generously provided 
by Dr. J. P. Allison (University of California, Berkeley, CA) and 
has been described previously (22). CTLA4-Ig is a fusion molecule 
containing the cytoplasmic domain of mouse CTLA4 and the hinge, 
C3'2,  C3~3, and C3~4 domains of human IgG1.  CTLA4-Ig-ex- 
pressing transfectants were generously provided by P. Lane (Basel 
Institute for Immunology, Basel, Switzerland).  CTLA4-Ig was iso- 
lated from the culture supernatant of these cells using a protein 
A-Sepharose column. II.,1 receptor agonist (tLA) (23) and murine 
I1.,2 were purchased from R&D Systems, Inc. (Minneapolis,  MN) 
and Cetus Corp. (Emeryville, CA), respectively. Murine I1.,4 and 
human Iblc~ were generously provided by the DNAX Research 
Institute (Palo Alto, CA) and Hoffmann-La Roche (Nutley, NJ), 
respectively. 
Cell Culture Conditions.  The Th2 cell lines used in this study 
were  maintained  as  described previously (19,  20).  Briefly,  l0  s 
D10.G4 or CDC-35 cloned Th2 cells were restimulated weekly 
in 24-well plates  with 200 #g/ml conalbumin (ConAlb) or 100 
/~g/ml  rabbit gamma globulin (RGG), respectively,  in complete 
RPMI  media  supplemented  with  10%  FBS,  2  x  106  T 
cell-depleted (CD4-,  CD8-,  Thy-1-) C3H/HeJ or BALB/cByJ 
(Jackson  Laboratories,  Bar  Harbor,  ME)  irradiated  (3,000  tad) 
splenocytes, 5 % Con A-stimulated rat spleen cell culture superna- 
tant, and 25 mM or-methyl mannoside.  At the end of a 7-d stimu- 
lation  cycle,  the  T  cells  were  isolated  by centrifugation  on  a 
Ficoll-Isopaque gradient. Where indicated, Th2 cells were further 
purified by passing the ceils over a nylon wool column to remove 
adherent cells, and IE + ceils were depleted by incubating the cells 
with an anti-IE mAb (14.4.4)  (24) and complement. Viable Th2 
cells were then isolated  by centrifugation on a Ficoll-Isopaque 
gradient. 
Proliferation Assays.  For proliferation assays involving spleno- 
cytes,  104 Th2 cells were cultured with the indicated number of 
T  cell-depleted irradiated (3,000 rad)  syngeneic spleen cells, an- 
tigen, and the indicated additions for 48 h at 37~  in a total volume 
of 100/zl in 96A/2 flat-bottom microtiter plates  (Costar, Cam- 
bridge, MA). T cell proliferation was determined by pulsing cul- 
tures with 0.5/zCi of [3H]thymidine for an additional 18 h, har- 
vesting with a sample harvester (Skatron, Sterling, VA) and counting 
incorporated [3H]thymidine. 
Antibody-coated plates were prepared with 96 A/2 flat-bottom 
microtiter plates (Costar) as described previously (25). In brief, wells 
were incubated with 50/xl PBS containing 4/~g/ml of the anti- 
c~//3 TCR mAb H57-597 (26) at 22~  for 2 h, followed by a post- 
coat with 5% FBS in PBS at 37~  for 30 min and multiple washes 
with  PBS containing  5%  FBS.  104 Th2 cells were cultured in 
mAb-coated wells with the indicated additions in a total volume 
of 100/xl for 48 h at 37~  pulsed  with 0.5 #Ci [3H]thymidine 
for 18 h,  and harvested for [3H]thymidine counting. 
Lyraphokine Assays.  HT-2 cells (21) were obtained from A. 
Abbas (Harvard Medical School, Boston, MA) and maintained in 
complete media supplemented with 5% FBS, 10% Con A-stimu- 
lated rat spleen cell culture supematant, and 25 mM a-methyl man- 
tAbbreviations used in this paper: ConAlb, conalbumin; FBS, fetal bovine 
serum; RA, receptor agonist; RGG, rabbit gamma globulin. 
noside. To determine 11-2 and Ib4 levels, dilutions ofT cell culture 
supernatants,  harvested 24 h after T cell stimulation, were cultured 
with 2,500 HT-2 cells in 96-weU A/2 plates for 24 h at 37~  The 
cultures were pulsed with 0.5/~Ci  [3H]thymidine the last  18 h, 
and the [3H]thymidine incorporation was determined. IL-2 versus 
Ib4 content was determined by including 10/~g/ml of either purified 
anti-Ib4, 11Bll (27), or purified anti-IL-2, $4B6 (28) mAb in the 
cultures. 
Flow Cytometry.  106 cells/ml were incubated in PBS containing 
5% FBS alone or with anti-CD28 mAb (1/20 dilution of ascites 
fluid) for 30 min on ice, washed extensively,  and incubated with 
a  1/12  dilution  of  FITC-conjugated  anti-hamster  IgG  mAb 
(CALTAG Laboratories, South San Francisco, CA) for an additional 
20 min on ice. After washing the cells extensively, they were ana- 
lyzed on a FACt  |  IV analyzer (Becton Dickinson & Co., Moun- 
tain View, CA). 
11_,1 PCR Analysis.  RNA was prepared from stimulated D10.G4 
or resident peritoneal cells with a guanidinium-isothiocyanate ex- 
traction in the presence  of carrier bacterial rRNA and ultracen- 
trifugation through a cesium chloride cushion (29). The D10.G4 
cells were purified before activation by passage over nylon wool 
and depleted of IE + cells to minimize contamination with APC 
(see above). Variable amounts of total cellular RNA corresponding 
to calculated input cell equivalents were subjected  to RT-PCR to 
measure the levels of IL-1 transcripts. PCR was carried out using 
conditions  suggested  by the  manufacturer of the  Ibl  primers 
(Stratagene Inc., La Jolla, CA). To amplify I1r  transcripts, re- 
verse transcription was primed with an 820-843-bp antisense primer, 
and the cDNA was amplified with the same primer and a 301-324- 
bp sense primer. To amplify IL-I-~ transcripts, a 756-776-bp an- 
tisense primer and a 330-350-bp sense primer were used. The posi- 
tive control 13-tubulin transcripts were amplified with a 24-54-bp 
sense transcript and 210-239-bp antisense transcript. PCR was car- 
ried out for 50 cycles (30). The PCR products were analyzed by 
electrophoresis on a 4%  agarose  gel. 
Results 
Anti-CD28 rnAb Can Costimulate Th2 CelI Proliferation.  To 
determine if Th2 ceils express surface CD28, the AKP,-derived 
Th2 clone D10.G4 (19) and BALB/c-derived Thl done T32 
were stained with mAb 37.51 (anti-CD28) (22) and a FITC- 
conjugated anti-hamster IgG mAb.  Analysis of the cells by 
flow cytometry demonstrated that D10.G4 Th2 cells and T32 
Thl cells express similar levels of cell surface CD28 protein 
(Fig.  1 a). 
Engagement of the TCR by antigen-MHC class II com- 
plexes can be mimicked by aggregation  of the TCR  with 
the use of immobilized anti-TCR antibodies. To determine 
if anti-CD28 mAb (mAb 37.51) costimulated Th2 prolifera- 
tion, D10.G4 and CDC-35 cells were cultured in weUs coated 
with anti-pan TCR-B mAb, H57-597 (26) and variable con- 
centrations  of soluble  anti-CD28  mAb.  Anti-CD28  mAb 
costimulated vigorous proliferation of both T cell clones (Fig. 
1, b and c). Both clones could also be costimulated by IL-lot 
(Fig. 1, see legend). As expected, little proliferation was ob- 
served when Th2 cells were cultured with anti-TCR mAb 
alone, or with anti-TCR mAb and an irrelevant control ham- 
ster mAb (anti-V3r3 TCR) (Fig.  1, b and c).  In no case did 
anti-CD28  mAb  alone stimulate D10.G4 cell proliferation 
(data not shown). These experiments indicate that CD28 sig- 
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Figure  1.  Anti-CD28 mAb can 
costimulate cloned Th2 cell prolifer- 
ation. (a) Cloned Th2 cells express 
cell surface CD28 as shown in this 
FACS  |  analysis of  cloned  T32 
Thl  cells and D10.G4  Th2  cells 
stained with the anti-CD28 mAb 
37.51 and a goat anti-hamster IgG- 
FITC. Staining with the second- 
step antibody alone is also shown. 
(b  and  c)  Anti-CD28  mAb  can 
costimulate  cloned  Th2  cells. 
D10.G4 Th2 cells (b) or CDC-35 
Th2 cells  (c) were cuhured in 96 A/2 
well plates coated with anti-TCR-B 
mAb (H57-597) and the indicated 
concentrations  of sohble purified 
anti-CD28 antibody (11) or an ir- 
relevant anti-V3,3 TCR mAb (O). 
The proliferative responses  were de- 
termined 48 h after stimulation. The 
proliferative response after stimula- 
tion with anti-TCK-/3 mAb and 1 
U/ml Ibl-cz was 39,729 cpm in the 
case of D10.G4 cells (b) and 55,416 
cpm in the case of CDC-35 cells (c). 
haling can substitute for exogenously added IL-1 in costim- 
ulating Th2 cell proliferation. 
Costimulation of T h2 Cell Proliferation by Anti-CD28 mAb 
Results  from Stimulation of  Responsiveness  to IL-4.  The response 
of  D10.G4 cells stimulated with immobilized anti-TCR mAb 
and anti-CD28 mAb was completely blocked by the addi- 
tion of neutralizing anti-IL-4 mAb, 11Bll  (27) but largely 
unaffected by anti-IL-2  mAb, $4B6 (28) (Fig. 2 a).  These 
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Figure 2.  CD28 costimulation acts at the level of Th2 cell responsive- 
ness to Ib4. (a) Costimulation of D10.G4 cell proliferation with immobi- 
lized anti-TCR antibody and anti-CD28 mAb is Ib4 dependent. D10.G4 
cells were cultured with plate-bound anti-TCR-~ mAb and the indicated 
concentrations  of soluble purified anti-CD28 mAb (11). Parallel sets of 
cultures also contained 10 #g/ml anti-lb4 mAb (Q) or 10 #g/ml anti-IL-2 
mAb (A). The proliferative responses of cultures stimulated with plate- 
bound anti-TCR and an irrelevant hamster anti-V'y3 TCR mAb are also 
shown (f~).  (b) Anti-CD28 mAb potentiates  D10.G4 cell proliferation 
to exogenous Ib4. D10.G4 cells were cultured with 5 U/ml of II.-4 and 
the indicated concentrations of purified anti-CD28 mAb (ll) or an irrele- 
vant anti-V~3 TCR mAb ([-]). The T cell proliferation observed in cul- 
tures containing  anti-CD28 is Ib4 dependent, as shown by its inhibition 
with 10 #g/ml anti-ID4 mAb (O), but not 10 #g/ml anti-Ib2 mAb (A). 
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data indicate that costimulation of Th2 cells mediated by anti- 
CD28 mAb acts through an IL-4 growth factor-dependent 
pathway, and not by induction of IL-2 production. 
To test whether anti-CD28 mAb increases the responsive- 
ness of Th2 cells to IL-4, D10.G4 cells were incubated with 
5 U/ml of rlL-4 and the indicated concentration of purified 
anti-CD28 mAb (Fig. 2 b). As has been shown previously, 
rested Th2 cells proliferate minimally when cultured with 
IL-4 alone ([7-9], Fig. 2 b). However, coculture with soluble 
anti-CD28 mAb increased D10.G4 cell proliferation  in re- 
sponse to IL-4 approximately  sixfold. Similar results were 
obtained with the CDC-35 Th2 clone (see  below, Fig. 4 d). 
A control hamster mAb, against the TCR V3r3, did not aug- 
ment D10.G4 or CDC-35 cell proliferation mediated by IL-4 
(Fig. 2 b and data not shown). These results demonstrate 
that CD28 costimulation induces responsiveness of Th2 cells 
to IL-4 in the absence of TCR engagement. The increase 
in Th2 cell responsiveness to IL-4 was not IL-2 dependent, 
as shown by the inability of the anti-IL-2 mAb $4B6 to in- 
hibit D10.G4 proliferation  (Fig. 2 b). 
CD28-B7-mediated Costimulation Does Not Increase Growth 
Factor Production by Th2 Cells.  CD28 costimulation with 
anti-CD28 mAb did not increase production of the growth 
factors IL-4 or IL-2 by Th2 cells. This was shown by testing 
the capacity of activated D10.G4 or CDC-35 cell culture su- 
pernatants to induce proliferation of  liT-2 indicator cells (21), 
which respond to both IL-4 and IL-2 (4). The titration curves 
revealed that the IL-4 content of  culture supernatants of CD28- 
costimulated cells was similar to that of cells stimulated by 
anti-TCR mAb alone (Fig. 3, a and b). The active growth 
factor in the culture supernatants  was identified as IL-4 by 
inhibition of the proliferation of  the HT-2 indicator cells with 
anti-IL-4 mAb but not with anti-IL-2 mAb (Fig. 3, a and 
b). Titrations of rlL-4 are shown for comparison. Therefore, D10.G4 
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Figure 3.  CD28-B7 costimulation of Th2 cell proliferation does not 
affect Ib4 production. (a and b) Costimulation  with anti-CD28 mAb does 
not increase Ib4 or Ib2 release by D10.G4 or CDC-35 cells. Cell culture 
supernatants  of D10.G4 cells (a) or CDC-35 cells (b) were titrated for 
growth-promoting activity on the IL-2/II~4-responsive  HT-2 indicator ceils. 
Supernatants from cells activated with plate-bound anti-TCP,-/9  mAb (4 
t~g/ml) (11) or with anti-TCR-/~ mAb and 75/~g/ml soluble CD28 mAb 
(0) were tested. In both cases the active growth factor was IL-4, as shown 
by the inhibition  of HT-2 proliferation with anti-IF4  mAb (open  symbols), 
but not anti-IL-2 mAb (hatched  symbols). Titrations of rlb4 (initial sample 
concentrations were 180 U/m1 (Fig. 3 a) and 60 U/ml (Fig. 3 b) are shown 
for comparison (A). The assays shown in a, b, and c were performed on 
separate days. (c and d) CTLA4-Ig does not inhibit Ib4 release by Th2 
cells. Similar levels of HT-2 proliferation were induced by ceil culture su- 
pernatants of D10.G4 cells (c) or CDC-35 cells (d) that were activated with 
plate-bound anti-TCR-B mAb (4/zg/ml) alone (m) or with anti-TCR-B 
mAb and 18/~g/ml CTLA4-1g (A). Supernatants from D10.G4 or CDC- 
35 calls cultured with 10  s T ceil-depleted syngeneic splenocytes without 
antigen served as a control to show that IL-4 release required TCR en- 
gagement  (A). The [3H]thymidine incorporation was determined 48 h 
later. The data in b and d are from the same experiment. 
although CD28-mAb-mediated costimulation induced in- 
creased growth factor (IL-2) production by Thl cells, it failed 
to induce production of IL-2 by Th2 cells and did not in- 
crease the level of IL-4 production by these ceUs. 
Some evidence suggests that Th2 ceils costimulate prolifer- 
ative responses of Thl cells (31, 32), raising the possibility 
that Th2 ceils express costimulatory molecules such as B7. 
These observations raise the possibility  that Th2 ceils can 
receive costimulatory signals from other Th2 ceils in culture. 
However, the level of B7 expressed by Th2 ceils is apparently 
insufficient to costimulate  IL-4 responsiveness or prolifera- 
tion of  Th2 cells (Figs. 1 and 2). Nevertheless, the possibility 
remained that the interaction of CD28 on Th2 cells with 
B7 on other Th2 cells is necessary for IL-4 production by 
Th2 cells in our experiments. To test this possibility, we used 
the B7 antagonist CTLA4-Ig, a genetically engineered soluble 
fusion protein derived from CTLA4, a second high-affinity 
receptor for B7. A saturating dose of CTLA4-Ig, sufficient 
to prevent B7-mediated costimulation of resting T cells and 
Thl cells ([33]; Fig. 6 and data not shown), was included 
in Th2 cultures stimulated with anti-TCR mAb, and the IL-4 
content of the culture supernatants was subsequently assayed 
with the use of HT-2 indicator  cells. A comparison  of the 
titration curves revealed that the inclusion of CTLA4-Ig in 
Figure 4.  Anti-CD28 mAb costimulation of Th2 cell proliferation is 
Ibl dependent. (a and c) CD28 costimulation of anti-TCR stimulated Th2 
cells is IL-1 dependent. D10.G4 (a) or CDC-35 (c) cells were stimulated 
with plate-bound anti-TCR-/9 mAb with or without the addition of 75 
/xg/ml purified anti-CD28 mAb. Parallel sets of cultures stimulated with 
plate-bound anti-TCR  mAb and anti-CD28 mAb were also incubated with 
250 ng/ml Ibl receptor antagonist  (II.,I RA) or a mixture of 10 ktg/ml 
anti-IL-l-c~  mAb and 10 #g/ml anti-IL-l-~/mAb  (ANTI-ILI;  a). The in- 
hibition by Ibl antagonists was not due to nonspecific toxicity because 
D10.G4 cell proliferation was restored with the addition of 5 U/m1 Ib2 
(II:1 RA/IL-2, 42,099 cpm; ANTI-Ibl/IL-2, 24,885 cpm). Both D10.G4 
and CDC-35 cells were depleted of IE + cells, and D10.G4 cells were fur- 
ther depleted of adherent cells as described in Materials and Methods.  (b 
and d) Responsiveness of Th2 cells to Ib4 is Ibl dependent.  D10.G4 (b) 
or CDC-35 (d) cells were stimulated with 5 U/m1 Ib4 alone or with the 
further addition of 75/~g/ml purified anti-CD28 mAb, and the prolifera- 
tive responses were measured. Parallel cultures contained in addition 250 
ug/ml I1--1 receptor antagonist (11_,1  RA) or a cocktail of 10/xg/ml anti- 
IL-l-(x mAb and 10/~g/ml anti-IL-18 mAb (ANTI-ILl;  b). The inhibi- 
tion by Ibl antagonists was not due to nonspecific  toxicity because  D10.G4 
cell proliferation was restored with the addition of 5 U/ml IIr  (IIA R.A/ 
1I.-2, 42,738 cpm;  ANTI-Ibl/IL-2, 26,180 cpm). 
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levels of IL-4 release induced by anti-TCR mAb (Fig. 3, c 
and d). HT-2 proliferation induced by each of these culture 
supernatants was abrogated with the addition of an anti-IL-4 
mAb, but not with an anti-IL-2 mAb (data not shown). To- 
gether these data suggest that IL-4 production by Th2 cells 
is independent of the B7-CD28  signaling  pathway. 
CD28 Costimulation of Th2 Cells Is IL-I Dependent.  Be- 
cause responsiveness of Th2 cells to IL-4 was stimulated by 
either anti-CD28 mAb or by IL-1, it was possible that the 
effects of CD28 signaling were mediated indirectly by IL-1. 
IL-1 inhibitors  were used to test this possibility. Vigorous 
D10.G4 cell proliferation was observed in cultures stimulated 
with anti-TCR mAb and anti-CD28 mAb, but the response 
was inhibited to background levels by purified IL-1 RA or 
by a mixture of anti-IL-lot and anti-IL-13 mAbs (Fig. 4 a). 
Similarly, the costimulation of CDC-35 cell proliferation with 
anti-CD28 mAb was inhibited by the addition of IL-1 RA 
(Fig. 4 c). The IL-1 inhibitors  also prevented the induction 
by anti-CD28 mAb of enhanced responsiveness of D10.G4 
and CDC-35 cells to exogenously  added IL-4, in the absence 
of TCR engagement (Fig. 4, b and d). These results demon- 
strate that costimulation through CD28 of Th2 cell IL-4 re- 
sponsiveness and proliferation  involves an IL-l-dependent 
mechanism. 
In the preceding experiments, no APC or other cells were 
added to the Th2 cell cultures,  and possible contaminating 
APC were depleted by passage of the Th2 cells over nylon 
wool columns and/or cytotoxic elimination of MHC class 
II + cells with anti-IE mAb plus complement (see legend to 
Fig. 4). These considerations suggest that the source of the 
IL-1 is the Th2 cells themselves. 
To determine if IL-1 transcripts were induced in Th2 cells 
after culture with anti-CD28 mAb, RT-PCR analysis was 
performed. IL-lot transcripts were detected as a 265-bp PCR 
product in RNA from D10.G4 cells costimulated with anti- 
CD28 mAb (Th2/TCR/CD28), but not in RNA from cul- 
tures stimulated with anti-TCR-~ mAb alone (Th2/TCR) 
(Fig. 5 a). This was confirmed  by Southern blot analysis  with 
an internal  IL-l-r~-radiolabeled  probe (Fig. 5 b). Based on 
comparisons of the titration of the RNA samples in this and 
another experiment, IL-lot transcript levels  were approximately 
5-10-fold lower in costimulated Th2 cells  than in LPS-activated 
peritoneal cells, a source of macrophages. Equivalent amounts 
of  intact RNA were used, as shown by RT-PCR amplification 
of B-tubulin transcripts.  It is unlikely that the IL-lc~ tran- 
scripts in the Th2 cultures arise from contaminating macro- 
phages, because  the LPS-activated  macrophageg a potent source 
of  IL-1, produce only 5-10 times more IL-lot transcripts than 
the Th2 cells. Furthermore, the Th2 cells had been depleted 
Figure 5.  CD28 signaling increases Iblc~ transcript levels in Th2 cells. (a) Total RNA was prepared from D10.G4 cells stimulated  for 12 h with 
anti-TCR-B mAb (Th2/TCR), alone or with the addition of anti-CD28 mAb (Th2/TCR/CD28). RNA from LPS-activated resident peritoneal cells 
(M~) was also analyzed as a positive control. Each RNA was analyzed by reverse transcription followed by PCR amplification of the cDNA from 
25,000, 5,000, and 1,000 cell equivalents, with primer pairs for mouse IL-lol (lanes 2-4) or IL-1B  (lanes 2-4). PCR with each primer pair was performed 
on all cell types in parallel. To control for the amount of RNA in each sample, 1,000, 200, and 40 cell equivalents of RNA were also analyzed by 
reverse transcription and PCR DNA amplification with a primer pair for B-tubulin (TUBULIN;  lanes 2-4) as described previously (43). PCR DNA 
amplification was also performed without reverse transcriptase to ensure that the observed bands did not result from amplification of genomic DNA. 
For the Iblc~ and IL-1B  primers, 25,000 cell equivalents were used and for tubulin, 1,000 cell equivalents were used (lane I). The PCR products were 
fractionated on a 2% agarose gel and visualized by ethidium bromide staining. Mspl-digested  pBR322  DNA fragments  served as markers (M). (b) 
Southern blot analysis of IL-I~ PCR products.  The gel shown in the top of a was blotted to a nitrocellulose membrane and the blot was hybridized 
with a 3zp-end-labeled  IL-la homologous oligonucleotide probe (516-546 bp) (44) by standard protocols. The resulting autoradiogram from the Southern 
blot is shown. 
1649  McArthur and Raulet of APC before stimulation (see Materials and Methods). Also 
arguing against the possibility that contaminating macro- 
phages were the source of the IL-1 transcripts was the obser- 
vation that no IL-1B transcripts (expected product, 447 bp) 
were detected in the costimulated Th2 cell RNA. IL-I~ tran- 
scripts were easily detected in RNA from control-activated 
macrophages (M~/LPS). These results indicate that CD28 
costimulation induces IL-lc~ (but not IL-I~) transcripts in 
Th2 cells, and suggests that induction of IL-lc~ production 
is the mechanism of CD28-mediated costimulation of Th2 
cells. 
Costimulation of Th2 Cells by Splenic APC Is Mediated by 
the CD28-B7 Pathway.  The previous experiments demon- 
strate that engagement of CD28 with an mAb is costimula- 
tory to Th2 cells, but do not indicate whether APC can 
costimulate Th2 cells via a B7-CD28-mediated interaction. 
To address this question, we investigated the effects of the 
B7 antagonist, CTLA4-Ig, on proliferation of Th2 cells in- 
duced by antigen and splenic APC (Fig. 6). CTLA4-Ig in- 
hibited antigen-dependent proliferation of both D10.G4 and 
CDC-35 Th2 cells in a dose-dependent fashion (Fig. 6, a and 
b). The proliferative responses of the CTLA4-Ig-containing 
cultures were restored by addition of IL-2,  demonstrating 
that the CTLA4-Ig was not toxic for the cells. The effects 
of CTLA4-Ig on these responses suggest that B7 signaling 
plays an important role in costimulation of Th2 cell prolifer- 
ation by splenic APC. 
The effects of CTLA4-Ig and IL-1 RA were compared for 
their capacity to inhibit proliferative responses of D10.G4 cells 
induced by antigen and splenic APC (Fig.  6 c). As in the 
previous experiment, CTLA4-Ig strongly blocked D10.G4 
proliferation induced by antigen and APC.  IL-1  RA also 
blocked D10.G4 proliferation, consistent with earlier reports 
(7) and with our finding that costimulation mediated by anti- 
CD28 mAb is an IL-l-dependent process. The combination 
of the two inhibitors was only slightly more inhibitory than 
either  alone.  The  inhibition  of D10.G4  proliferation by 
CTLA4-Ig and IL-1 RA was not due to toxicity of the re- 
agents, because the addition of IL-2 restored the proliferative 
response. Taken together, these results indicate that B7-CD28- 
mediated costimulation plays an important role in the responses 
of Th2 cells to antigen presented by splenic APC. The de- 
pendence of the responses on IL-1 production, presumably 
by the responding Th2 cells, suggests that IL-1 production 
occurs as an intermediate step. 
Costimulation of Th2 Cell Proliferation by IL-1 Is Independent 
of the B7-CD28 Pathway.  The preceding data do not ad- 
dress the possibility that IL-1- and CD28-mediated signals 
are both essential  to synergistically  activate Th2 cells. Al- 
though Th2 cells are costimulated by exogenous IL-1 in the 
absence of APC, Th2 cells may themselves express costimula- 
tory  molecules,  as  noted  earlier.  To  determine whether 
costimulation of Th2 cells mediated by exogenous IL-1 re- 
quires B7-mediated interactions, we used the B7 antagonist 
CTLA4-Ig.  The addition of increasing concentrations of 
CTLA4-Ig, up to 10/~g/ml, failed to inhibit the prolifera- 
tive response costimulated by exogenous IL-lc~ (Fig. 7). This 
concentration of CTLA4-Ig is suf~cient to strongly inhibit 
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Figure  6.  B7-CD28 signaling is involved in stimulation of Th2 cells 
by splenic APC and antigen. CDC-35 (a) and D10.G4 (b) ceUs  were stimu- 
lated with 2  x  105 T-depleted  irradiated (3,000  rad) syngeneic  spleno- 
cytes and antigen (RGG or Con Alb, respectively) and increasing concen- 
trations of CTLA4-Ig (m). As a control for toxicity of the CTLA4-Ig, 
the inhibition caused by the highest dose of CTLA4-Ig was reversed with 
the addition of 5 U/m1 rib2 (O).  The Th2 cells were also stimulated 
with 4/~g/ml plate-bound anti-TCR mAb and the indicated concentra- 
tion of CTLA4-1g (A). (c) D10.G4 cells were stimulated with the indi- 
cated number of T cell-depleted irradiated syngeneic splenocytes and 100 
/~g/ml antigen (Con Alb) (II). Parallel sets of cultures contained 10/~g/ml 
CTLA4-Ig (A), 250 ng/ml II:1 RA (A), or both (e), and the prolifera- 
tive responses were determined by [3H]thymidine incorporation 48 h after 
stimulation. As a control for toxicity of the reagents, proliferation of antigen- 
stimulated D10.G4 cell cultures inhibited with a mixture of CTLA4-Ig 
and I1:1 RA was restored by the further addition of 10 U/ml of ri1:2 (O). 
various B7-mediated costimulation events, including costimu- 
lation of Thl cells ([34]; data not shown) and costimulation 
of Th2 cells by splenic APC (Fig. 6). Furthermore, titrations 
of IL-loe together with CD28 mAb revealed no synergy in 
induction of proliferation of Th2 cells stimulated with anti- 
TCR mAb (data not shown). Together these results suggest 
that costimulation in vitro by exogenous IL-1  is indepen- 
dent of B7-CD28 interactions. 
1650  CD28 Signal Costimulates Th2 Cell Responsiveness  to Ib4 Figure 7.  Ibl costimulation  of Th2 cells  does not require  B7-CD28 
signaling. D10.G4 cells were cultured in half-area  96-plate wells coated 
with 4 #g/ml immobilized  anti-TCR-• mAb alone or with the further 
addition of I U/ml Iblcx.The  indicated  concentrations  of CTLA4-1g  were 
added to parallel  cultures,  and the proliferative  responses  were  determined 
by [3Hlthymidine  incorporation  48 h after stimulation. 
Discussion 
Based on the finding that IL-1 costimulates Th2 cell prolifer- 
ation, it has often been assumed that Th2 cell activation re- 
quires costimulation by APC-derived IL-1.  We have now 
shown that CD28-B7 interactions can costimulate prolifera- 
tion of two independently derived Th2 clones. The costimu- 
lation of Th2 cell responses mediated by CD28 provides an 
explanation for the ability of cells that produce little or no 
IL-1,  such as dendritic cells and activated B cells  (18,  34), 
to costimulate Th2 cell proliferation.  Both of these APC types 
express B7 (35, 36).  Further studies will be necessary to de- 
termine whether a similar mechanism holds in the case of 
IL-4-dependent Th cells  in vivo. 
B7-mediated signaling is apparently the predominant source 
of Th2 costimulation in splenocyte populations, based on the 
demonstration that the B7 antagonist CTLA4-Ig strongly 
blocked Th2 cell proliferation. Although cells capable of IL-1 
production  (e.g.,  macrophages) are present among splenic 
APC, and could in principle directly costimulate Th2 cells 
by releasing IL-1, our results suggest that they fail to secrete 
sufficient IL-1 to trigger Th2 cells. Perhaps these cells lack 
a sufficient activating signal to induce maximal IL-1 release, 
at least in the in vitro culture system used. Instead, our results 
suggest that signaling via direct T cell-APC contact may be 
required for effective Th2 costimulation, consequent auto- 
trine IL-1 production, and IL-4 responsiveness.  If this holds 
true for IL-4-dependent T cells in vivo, these costimulatory 
requirements may help to tightly regulate antigen-specific re- 
sponses of Th2 cells under steady state conditions. On the 
other hand, in cases of serious infections, where circulating 
IL-1 can achieve sustained high levels,  the requirement for 
costimulation mediated by cell contact may be relaxed in the 
interests of promoting a vigorous and rapid response of Th2 
cells. In this case, antigen presented even by B7-negative APC, 
such as resting B cells,  could lead to a Th2 cell response. 
Costimulation of Thl cell proliferation has been previously 
shown to involve increased IL-2 production (5, 37). In con- 
trast, the costimulation of  Th2 cell proliferation by anti-CD28 
mAb is not mediated through increased IL-2 or IL-4 secre- 
tion. Rather, CD28 costimulation induces IL-1 production, 
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apparently by the Th2 cells themselves, which then acts in 
an autocrine fashion to induce increased responsiveness of the 
cells to IL-4. It is unlikely that APC contamination was respon- 
sible for the IL-1 production in our experiments, because APCs 
were depleted from the Th2 population and because IL-1/3 
transcripts, which are present in macrophages ([38]; Fig. 5), 
were absent in the D10.G4  RNA preparations. 
We do not yet know whether costimulation of IL-1 produc- 
tion by Th2 cells involves induction of IL-1 gene transcrip- 
tion and/or stabilization of IL-1 transcripts. Both mechanisms 
are involved in costimulation of IL-2 gene expression in Thl 
cells  by  CD28  mAb  (14,  39).  Regulated  stabilization  of 
cytokine transcripts has been associated with the presence of 
specific  sequence repeats (AUUUA) in the 3'  untranslated 
segment of the mKNA. These sequences have been found 
in all of the transcripts previously known to be stabilized by 
CD28 mAb costimulation (40,  41).  Interestingly, such se- 
quences are also found in the 3' untranslated region of the 
IL-lol transcript (40), suggesting that message stabilization 
may be involved in costimulation of IL-1 production via CD28 
signaling. 
Other groups have reported that Th2 cells synthesize IL-1 
(42, 43). However, Zubiaga et al. (43) reported that exoge- 
nous costimuli are not required for proliferation of Th2 cells 
cultured at high cell densities. Under those conditions, Th2 
cells reportedly produce IL-lol and proliferate after stimula- 
tion with a variety of mitogens. This effect may be related 
to the findings that Th2 cells, in sufficiently high numbers, 
can costimulate proliferative responses of Thl cells (31, 32), 
suggesting that Th2 cells can express costimulatory ligands. 
Presumably, the dependence of our responses on exogenous 
costimulation is due to the use of lower Th2 cell concentra- 
tions. In vivo, it is likely that the concentrations of activated 
costimulatory Th2 cells are too low in most circumstances 
to circumvent the necessity for APC-derived costimuli. 
Thl cells can also proliferate in response to exogenously 
provided IL-4.  Interestingly, responsiveness of Thl cells to 
IL-4 was shown to depend on a costimulatory signal that 
is sensitive to chemical fixation (44). Thl cell responsiveness 
to  IL-4 was not mediated by IL-2.  Although the identity 
of the costimulatory molecule mediating IL-4 responsiveness 
by Thl cells has not yet been reported, it appears  likely to 
be B7. Interestingly, in contrast to Th2 cells, there is no evi- 
dence to indicate that Thl cells produce IL-1 or that they 
can respond to it  (7,  8).  In fact, Thl  cells reportedly lack 
cell surface receptors for IL-1 (7, 45). These considerations 
raise the possibility that IL-4 responsiveness of Thl cells is 
mediated by a distinct mechanism from that of Th2 cells. 
With  the  addition  of  our  results,  it  appears  that 
CD28-B7-mediated costimulation plays a role in the activa- 
tion of most if not all types of T  cells, suggesting that this 
signaling mechanism arose early in the evolution of T cells. 
In a practical vein, these findings enhance optimism that ther- 
apeutic approaches based on blocking the B7 costimulation 
pathway of Th cells will be effective. A therapeutic approach 
with particular promise is based on the premise that blocking 
costimulatory signals during immune responses to transplanted 
tissue,  autoantigens, or allergens will render the individual tissue, autoantigens, or allergens will render the individual 
unresponsive to subsequent challenges.  However, anergy in- 
duction has not been demonstrated in the case of Th2 cells, 
raising some doubts as to whether the approach would be 
effective in the case of Th2-dependent responses.  With the 
knowledge  that  Th2  cells  are  responsive  to  CD28-B7- 
mediated costimulatory signals, the possibility that blockade 
of B7 will lead to anergy of  Th2 cells can be directly examined. 
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